<DOC>
	<DOCNO>NCT01522235</DOCNO>
	<brief_summary>The purpose study see administer intravenous immune globulin ( IVIG ) ( put immune globulin directly blood ) help improve symptom orthostatic hypotension ( sudden fall blood pressure person stand ) quality life men woman autoimmune autonomic ganglionopathy ( AAG ) .</brief_summary>
	<brief_title>Evaluating Effectiveness Intravenous Immunoglobulin Therapy Autoimmune Autonomic Ganglionopathy</brief_title>
	<detailed_description>Autoimmune autonomic ganglionopathy ( AAG ) rare disease result severe dysautonomia ( disorder autonomic nervous system function ) . Many patient unable carry activity daily live due autonomic symptom respond well therapy ( drop blood pressure stand ) . The recent discovery antibody cause AAG stimulate interest immunomodulatory therapy ( therapy modify function immune system ) . Studies positive clinical response therapy report patient AAG use immunomodulatory therapy treatment . The investigator plan carry blind , randomize trial use IVIG . There report randomized clinical trial immunosuppressive agent AAG . The proposed study , successful , provide first reliable clinical evidence , therapy IVIG effective treatment AAG . Treatment symptoms autonomic failure effective mild case . Most patient require therapy would change course disease , present establish therapeutic regimen . The natural course untreated AAG known . To address unresolved issue , clinical trial follow goal : 1 . To measure effect IVIG treatment orthostatic hypotension , autonomic symptom quality life score patient participant AAG . 2 . To determine durability IVIG ( long treatment effective ) orthostatic hypotension , autonomic symptom quality life score patient participant AAG .</detailed_description>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>1 . Participants age 18 85 2 . Participants neurogenic orthostatic hypotension ( fall systolic blood pressure &gt; 30 mmHg ) . 3 . Symptoms orthostatic intolerance . 4 . Antibodies neuronal AChR autonomic ganglion &gt; 0.2nmol/l . Results must within 6 month screen visit may immunomodulatory intervention since time antibody measurement sample need reconfirm screen . 5 . Participants must willing withdraw medication affect vasoactive autonomic function 5 halflives test ( exception stable dose fludrocortisone 0.2 mg/day ) adhere regular diet 1 . Women childbearing potential ( WOCP ) use medically accept contraception 2 . Pregnant lactate female participant become pregnant trial longer receive IVIG , follow part intention treat protocol . 3 . Severe depression and/or anxiety ( score &gt; 29 Beck Depression Inventory score Beck Anxiety Inventory â‰¥ 36 ) 4 . Active psychosis ineligible , history psychosis eligible , review patient PCP and/or treat mental health provider . 5 . History asthma 6 . Other cause autonomic failure ( e.g. , diabetes , amyloidosis ) 7 . History allergic anaphylactic reaction humanize murine antibody . 8 . History presence recurrent chronic infection ( recurrent infection define &gt; 4 time per year ) . 9 . History cancer , include solid tumor hematologic malignancy ( except fully resolve resect cutaneous basal cell squamous cell carcinoma skin ) 10 . History presence vascular disease potentially affect brain spinal cord ( e.g. , stroke , transient ischemic attack , carotid stenosis ( great 80 % ) , aortic aneurysm , intracranial aneurysm , hemorrhage , arteriovenous malformation ) 11 . History severe , clinically significant central nervous system trauma ( e.g. , cerebral contusion , spinal cord compression ) 12 . History presence infectious cause encephalopathy myelopathy ( e.g. , syphilis , Lyme disease , human Tcell lymphotropic virus type 1 [ HTLV1 ] , herpes zoster myelopathy ) 13 . History thromboembolic event deep vein thrombosis 14 . Platelet count &lt; 100,000/mL , Hemoglobin &lt; 8.5 g/dL , Neutrophils &lt; 1.5 x 103/mL . 15 . Serum IgA deficiency : Immunoglobulin A ( IgA ) level &lt; 7 mg/dL . 16 . History immunosuppression HIV/AIDS 17 . History cardiac arrhythmia angina , electrocardiogram ( ECG ) show significant abnormality treat investigator determines may jeopardize participant 's health ( i.e. , acute ischemia , leave bundle branch , bifascicular block ) 18 . History renal failure creatinine &gt; 2.0 19 . History previous allergic response albumin . 20 . Treatment IVIG plasma exchange within 6 week study enrollment . 21 . Active adjustment immunomodulatory treatment . Patients stable dos immunomodulatory medication ( dose change within 4 month include , limited prednisone , mycophenolate mofetil azathioprine ) still elevate antibody titer meet criterion inclusion allow participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Autoimmune autonomic neuropathy</keyword>
	<keyword>Orthostatic hypotension</keyword>
	<keyword>Dysautonomia</keyword>
	<keyword>Autonomic failure</keyword>
	<keyword>Peripheral autonomic neuropathy</keyword>
</DOC>